Indian pharmaceutical company Wockhardt has told the government it can produce as many as two billion doses a year of most Covid-19 vaccines, starting with a capacity of 500 million doses by February 2022. It is also in the process of “accessing” some of the technology to make Covid-19 vaccines. Outside of India, Wockhardt already has an agreement with the UK government to “fill and finish” Covid-19 vaccines exclusively for the UK. As per the agreement, its capacity will be used for other Covid-19 vaccines the UK government requires it to fill and finish. Wockhardt is planning to “quickly” establish the capacity to make 500 million doses a year of “any” Covid-19 vaccine using these platforms.

Source: Indian Express May 25, 2021 22:30 UTC